Research Proposal Example Oxford

INSTITUTIONAL RESEARCH PROPOSAL AND SERVICES AGREEMENT

Document ID: IRPSA-2024-OXF-089
Effective Date: [Effective Date]
Version: 4.2 (Institutional Grade)
Governing Jurisdiction: England and Wales (subject to cross-border arbitration provisions)

---

1. STATUTORY & LEGAL COMPLIANCE NOTICE

CRITICAL LEGAL NOTICE: This document is an institutional-grade legal instrument designed to govern complex academic, scientific, or commercial research engagements modeled upon rigorous institutional standards (including those traditionally observed within the University of Oxford ecosystem). This Agreement contains binding obligations regarding intellectual property assignment, liability limitation, confidentiality, and dispute resolution.

Execution of this Agreement by authorized representatives binds the respective legal entities to all terms herein. Legal counsel review is strongly advised prior to execution to ensure complete alignment with local statutory frameworks, tax regulations, and institutional policies.

---

2. PARTIES & RECITALS

This Institutional Research Proposal and Services Agreement (the "Agreement") is entered into and made effective as of [Effective Date] (the "Effective Date"), by and between:

Research Provider: [Company Full Legal Name], a [State/Country of Incorporation] [corporation/limited liability company/academic institution], having its principal place of business at [Principal Address] (hereinafter referred to as the "Institution"), and

Client / Sponsor: [Client Full Legal Name], a [State/Country of Incorporation] [corporation/limited liability company/entity], having its principal place of business at [Principal Address] (hereinafter referred to as the "Sponsor").

RECITALS:

WHEREAS, the Institution possesses world-class expertise, specialized infrastructure, and academic personnel capable of conducting advanced empirical, theoretical, and applied research;

WHEREAS, the Sponsor desires to engage the Institution to perform certain specific research activities as outlined in the research proposal incorporated herein; and

WHEREAS, the Parties intend to establish a clear legal, operational, and financial framework governing the execution of the research, the allocation of resulting intellectual property, and the protection of confidential information.

NOW, THEREFORE, in consideration of the mutual covenants, promises, and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

---

3. EXHAUSTIVE OPERATIVE CLAUSES & LEGAL TERMS

SECTION 1: SCOPE OF SERVICES & ENGAGEMENT

1.1 Engagement. The Sponsor hereby engages the Institution, and the Institution accepts such engagement, to perform the research services (the "Research Services") detailed in the Research Proposal attached hereto as Schedule A (the "Scope of Work"). 1.2 Performance Standard. The Institution shall perform the Research Services in a professional, workmanlike manner, exercising the highest standards of scientific rigor, professional diligence, and academic integrity customary in advanced research institutions of international standing. 1.3 Academic Freedom and Publication. The Institution and its participating researchers shall retain the absolute academic freedom to publish, present, or otherwise publicly disclose the methods, results, and findings derived from the Research Services, subject to the review procedures set forth in Section 5 herein regarding Confidential Information and patent protection. 1.4 Key Personnel. The research activities shall be directed by [Principal Investigator Name] as the Principal Investigator. If the Principal Investigator becomes unable or unwilling to continue the research, the Institution shall promptly notify the Sponsor and propose a qualified substitute acceptable to the Sponsor, acting reasonably.

SECTION 2: COMPENSATION & PAYMENT TERMS

2.1 Total Consideration. In consideration for the performance of the Research Services and the rights granted herein, the Sponsor shall pay to the Institution the total sum of [Amount in USD] (USD [Numeric Amount]), payable in accordance with the milestone schedule set forth in Schedule B (the "Milestone Payment Schedule"). 2.2 Invoicing. The Institution shall issue invoices to the Sponsor in accordance with the Milestone Payment Schedule or upon the completion of specific research phases. All invoices shall be sent to the billing address designated by the Sponsor: [Sponsor Billing Address / Email]. 2.3 Payment Due Date. All undisputed invoices shall be paid by the Sponsor within thirty (30) calendar days of the date of issuance (Net 30). Payments shall be made in United States Dollars (USD) via wire transfer to the bank account designated in writing by the Institution. 2.4 Late Interest. Any undisputed amount not paid when due shall accrue interest at the lesser of one and one-half percent (1.5%) per month or the maximum rate permitted by applicable law, calculated daily and compounded monthly from the date due until paid in full. 2.5 Taxes. The compensation amounts set forth herein are exclusive of all applicable taxes, duties, levies, and tariffs. The Sponsor shall be solely responsible for all sales, use, value-added (VAT), and similar taxes imposed by any taxing authority, excluding taxes based solely on the net income of the Institution.

SECTION 3: TERM & TERMINATION

3.1 Term. This Agreement shall commence on the Effective Date and shall continue in full force and effect until [Completion Date] or until the Research Services are fully completed and all deliverables are accepted, unless earlier terminated in accordance with this Section 3 (the "Term"). 3.2 Termination for Convenience. The Sponsor may terminate this Agreement, in whole or in part, at any time for its convenience upon providing ninety (90) calendar days' prior written notice to the Institution. Upon receipt of such notice, the Institution shall immediately cease all non-essential research activities and take all reasonable steps to mitigate costs. 3.3 Termination for Material Breach. Either Party may terminate this Agreement immediately upon written notice if the other Party materially breaches any of its obligations hereunder and fails to cure such material breach within thirty (30) calendar days after receipt of written notice detailing the specific breach. 3.4 Consequences of Termination. Upon termination of this Agreement for any reason: (a) The Sponsor shall pay the Institution for all Research Services performed, non-cancellable commitments incurred, and direct costs accrued up to the effective date of termination, pro-rata based on the Milestone Payment Schedule or actual incurred costs. (b) Each Party shall promptly return or destroy all Confidential Information of the other Party in accordance with Section 5.

SECTION 4: INTELLECTUAL PROPERTY OWNERSHIP

4.1 Background Intellectual Property. Each Party shall retain sole and exclusive ownership of all intellectual property, know-how, data, materials, and technology developed, acquired, or owned prior to the Effective Date or independently of this Agreement ("Background IP"). No license to Background IP is granted or implied except as strictly necessary to perform the Research Services. 4.2 Foreground Intellectual Property (Results). All inventions, discoveries, software, data, copyrightable works, and other intellectual property conceived, generated, or reduced to practice strictly through the performance of the Research Services (collectively, "Foreground IP") shall be owned exclusively by the Institution, subject to the commercial option rights granted to the Sponsor in Section 4.3. 4.3 Commercial Option. The Institution hereby grants to the Sponsor an exclusive, time-limited option to negotiate a commercial license to the Institution's rights in the Foreground IP upon commercially reasonable terms, to be negotiated in good faith for a period of ninety (90) calendar days following the written disclosure of such Foreground IP to the Sponsor. 4.4 Academic and Research License. Notwithstanding anything to the contrary, the Institution retains an irrevocable, royalty-free, worldwide license to use all Foreground IP and research data for non-commercial academic research, teaching, and publication purposes.

SECTION 5: MUTUAL CONFIDENTIALITY & NON-DISCLOSURE

5.1 Definition of Confidential Information. "Confidential Information" means all non-public, proprietary information disclosed by one Party (the "Disclosing Party") to the other Party (the "Receiving Party") under this Agreement, whether orally or in writing, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure. 5.2 Obligations of Confidentiality. The Receiving Party shall: (a) Protect the Disclosing Party's Confidential Information with the same degree of care it uses for its own confidential information, but in no event less than a reasonable standard of care; (b) Not disclose the Confidential Information to any third party, except to its directors, officers, employees, legal counsel, and academic researchers who have a need to know and are bound by confidentiality obligations at least as restrictive as those herein; and (c) Use the Confidential Information solely for the purpose of fulfilling its obligations or exercising its rights under this Agreement. 5.3 Exclusions. Confidential Information shall not include information that: (a) Is or becomes generally known to the public through no breach of this Agreement by the Receiving Party; (b) Was already known to the Receiving Party prior to disclosure without an obligation of confidentiality; (c) Is independently developed by the Receiving Party without reference to or use of the Disclosing Party's Confidential Information; or (d) Is rightfully received from a third party without restriction on disclosure. 5.4 Publication Review. Prior to submitting any manuscript, abstract, or presentation containing the Sponsor's Confidential Information or derived Foreground IP for public release, the Institution shall provide the Sponsor with a copy of the proposed publication at least thirty (30) calendar days prior to submission. The Sponsor may request the redaction of its Confidential Information or a delay (not to exceed sixty (60) additional calendar days) to allow for the filing of patent applications.

SECTION 6: REPRESENTATIONS & WARRANTIES

6.1 Mutual Representations. Each Party represents and warrants that: (a) It is duly organized, validly existing, and in good standing under the laws of its jurisdiction of incorporation; (b) It has all requisite corporate power and authority to execute, deliver, and perform its obligations under this Agreement; and (c) The execution and performance of this Agreement do not violate any law, regulation, court order, or agreement to which it is bound. 6.2 Institution Warranties. The Institution warrants that the Research Services will be performed with reasonable care and skill by personnel possessing appropriate qualifications and expertise. 6.3 Disclaimer of Warranties. EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 6, THE RESEARCH SERVICES AND ALL RESULTS, DATA, AND INTELLECTUAL PROPERTY ARE PROVIDED "AS IS." THE INSTITUTION MAKES NO OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT.

SECTION 7: LIMITATION OF LIABILITY & INDEMNIFICATION

7.1 Consequential Damages Waiver. Neither Party shall be liable to the other for any indirect, incidental, consequential, special, punitive, or exemplary damages, including loss of profits, loss of revenue, loss of data, or business interruption, arising out of or in connection with this Agreement, even if advised of the possibility of such damages. 7.2 Cap on Liability. The total aggregate liability of either Party arising out of or relating to this Agreement, under any legal theory (contract, tort, negligence, strict liability, or otherwise), shall be strictly limited to the total fees actually paid or payable by the Sponsor to the Institution under this Agreement during the twelve (12) month period preceding the event giving rise to liability. 7.3 Indemnification by Sponsor. The Sponsor shall defend, indemnify, and hold harmless the Institution, its governing board, officers, employees, agents, and participating researchers from and against any third-party claims, liabilities, losses, damages, and expenses (including reasonable legal fees) arising out of or resulting from: (a) The commercialization, manufacture, distribution, or use of the Foreground IP or products derived therefrom by the Sponsor; (b) Any material breach of this Agreement by the Sponsor; or (c) The gross negligence or willful misconduct of the Sponsor.

SECTION 8: DISPUTE RESOLUTION & ARBITRATION

8.1 Negotiation. In the event of any dispute, controversy, or claim arising out of or relating to this Agreement, the Parties shall first attempt in good faith to resolve the matter through senior management negotiations within thirty (30) calendar days of written notice of the dispute. 8.2 Binding Arbitration. If the dispute is not resolved through negotiation, it shall be finally settled by binding arbitration administered by the London Court of International Arbitration (LCIA) in accordance with the LCIA Arbitration Rules then in force. 8.3 Arbitration Details. The number of arbitrators shall be one (1). The place of arbitration shall be London, England. The language to be used in the arbitral proceedings shall be English. The award rendered by the arbitrator shall be final and binding upon both Parties and may be enforced in any court of competent jurisdiction.

SECTION 9: GOVERNING LAW & JURISDICTION

9.1 Governing Law. This Agreement, and all claims or causes of action arising out of or relating to it, shall be governed by, construed, and enforced in accordance with the substantive laws of England and Wales, without regard to its conflict of laws principles. 9.2 Jurisdiction. Subject to Section 8, the Parties irrevocably submit to the exclusive jurisdiction of the courts of England and Wales for any legal action or proceeding arising out of this Agreement.

SECTION 10: MISCELLANEOUS

10.1 Severability. If any provision of this Agreement is held to be invalid, illegal, or unenforceable by a court or arbitrator of competent jurisdiction, such provision shall be modified to the minimum extent necessary to make it valid and enforceable, and the remaining provisions shall remain in full force and effect. 10.2 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Execution may be effected via electronic signature (e.g., DocuSign, Adobe Sign), which shall have the same legal force and effect as a handwritten signature. 10.3 Entire Agreement. This Agreement, together with Schedules A and B, constitutes the entire agreement between the Parties concerning the subject matter hereof and supersedes all prior and contemporaneous negotiations, understandings, proposals, and agreements, whether written or oral. 10.4 Force Majeure. Neither Party shall be liable for any failure or delay in performance under this Agreement (other than payment obligations) resulting from causes beyond its reasonable control, including acts of God, war, terrorism, pandemics, labor strikes, natural disasters, or utility failures.

---

4. EXECUTION & FORMAL SIGNATURE BLOCKS

IN WITNESS WHEREOF, the Parties hereto have caused this Institutional Research Proposal and Services Agreement to be duly executed by their respective authorized representatives as of the Effective Date written above.

FOR [COMPANY FULL LEGAL NAME] (INSTITUTION):

Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Company Full Legal Name]
Date: [Date]

---

FOR [CLIENT FULL LEGAL NAME] (SPONSOR):

Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Client Full Legal Name]
Date: [Date]

---

5. SCHEDULE A: SCOPE OF WORK (RESEARCH PROPOSAL)

(To be populated with specific technical objectives, milestones, deliverables, and methodology)

1. Research Objectives: [Detailed technical description of research goals, hypotheses, and expected deliverables]
2. Methodology: [Empirical, theoretical, or laboratory methodologies to be deployed]
3. Timeline & Milestones: [Phased breakdown of research progression over the Term]

---

6. SCHEDULE B: MILESTONE PAYMENT SCHEDULE

(To be populated with financial installments linked to Schedule A milestones)

1. Milestone 1: Execution of Agreement & Initiation of Research – [Amount in USD] ([Due Date])
2. Milestone 2: Delivery of Mid-Term Progress Report – [Amount in USD] ([Due Date])
3. Milestone 3: Delivery of Final Research Report & Data Deliverables – [Amount in USD] ([Due Date])

---

7. STEP-BY-STEP EXECUTION & FILING GUIDE

1. Document Preparation (Word/Google Docs):

   • Open this template in a secure word processor.
   • Utilize the Find and Replace function to locate and replace all bracketed placeholders (e.g., [Company Full Legal Name], [Client Full Legal Name], [Principal Address], [Effective Date], [Amount in USD]) with exact, verified legal entities and financial figures.
   • Ensure Schedules A and B are comprehensively drafted and attached.

2. Signatory Authority Verification:

   • Confirm that the individuals signing on behalf of both the Institution and Sponsor hold corporate authority (e.g., Director, CEO, Authorized Officer, or delegated academic signatory) to bind their respective legal entities.

3. Digital Execution (DocuSign / Adobe Sign):

   • Export the finalized agreement as a secure PDF.
   • Upload the PDF to an enterprise electronic signature platform (such as DocuSign or Adobe Sign).
   • Route signature requests to the designated authorized signatories with multi-factor authentication enabled if required.

4. Post-Execution Filing & Record Retention:

   • Upon full execution, download the executed PDF along with the digital certificate of completion.
   • Archive the master document in the institutional contract management repository under Document ID IRPSA-2024-OXF-089.
   • Provide certified copies to the finance department for billing setup and to the Principal Investigator for operational execution.